FDA Adverse Event Injury Summary report: N

IMPLANTABLE NEUROSTIMULATOR

MDR report key: 15374001 · Received September 7, 2022

Report

Report Number
2182207-2022-01705
Event Type
Injury
Date Received
September 7, 2022
Report Date
September 7, 2022
Manufacturer
MEDTRONIC NEUROMODULATION
Product Code
LGW
PMA / PMN Number
P840001
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NL
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

LITERATURE CITATION: ZUIDEMA Z, VAN DAAL ELKE, VAN GEEL IRIS, DE GEUS TJ, VAM KUIJK MJ, DE GALAN BE, DE MEIJ N, VAN ZUNDERT J. LONG-TERM EVALUATION OF SPINAL CORD STIMULATION IN PATIENTS WITH PAINFUL DIABETIC PERIPHERAL NEUROPATHY: AN 8-10-YEAR PROSPECTIVE COHORT STUDY LITERATURE ABSTRACT: THE ARTICLE AIMED TO EVALUATE THE LONG-TERM EFFECTS OF SPINAL CORD STIMULATION (SCS) IN PATIENTS WITHPAINFUL DIABETIC POLYNEUROPATHY (PDPN). THE AUTHORS ULTIMATELY CONCLUDED THAT THE 8-10-YEAR FOLLOW-UP STUDY INDICATED THAT SCS REMAINED AN EFFECTIVE TREATMENT ON THE LONG-TERM TO REDUCE PAIN INTENSITY IN PDPN PATIENTS. AGE OR DATE OF BIRTH: THIS VALUE IS THE AVERAGE AGE OF THE PATIENTS REPORTED IN THE ARTICLE AS SPECIFIC PATIENTS COULD NOT BE IDENTIFIED. SEX: THIS VALUE REFLECTS THE SEX OF THE MAJORITY OF THE PATIENTS REPORTED IN THE ARTICLE AS SPECIFIC PATIENTS COULD NOT BE IDENTIFIED. EVENT: IT WAS NOT POSSIBLE TO ASCERTAIN SPECIFIC DEVICE INFORMATION FROM THE ARTICLE OR TO MATCH THE REPORTED EVENTS WITH PREVIOUSLY REPORTED EVENTS. CORRESPONDENCE HAS BEEN SENT TO THE AUTHOR OF THE ARTICLE INQUIRING ABOUT INDIVIDUAL PATIENT INFORMATION AND ADDITIONAL INFORMATION REGARDING THE REPORTED EVENTS. CONCOMITANT MEDICAL PRODUCTS: PRODUCT ID: NEU_INS_STIMULATOR, LOT#: UNKNOWN, PRODUCT TYPE: IMPLANTABLE NEUROSTIMULATOR. PRODUCT ID: NEU_UNKNOWN_LEAD, LOT#: UNKNOWN, PRODUCT TYPE: LEAD. OTHER APPLICABLE COMPONENTS ARE: PRODUCT ID: NEU_INS_STIMULATOR, SERIAL/LOT #: UNKNOWN, UBD: ASKU, UDI#: ASKU; PRODUCT ID: NEU_UNKNOWN_LEAD, SERIAL/LOT #: UNKNOWN, UBD: ASKU, UDI#: ASKU. MEDTRONIC IS SUBMITTING THIS REPORT TO COMPLY WITH FDA REPORTING REGULATIONS UNDER 21 CFR PARTS 4 AND 803. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION AND HAS PROVIDED AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY ¿DEFECTS¿ OR HAS ¿MALFUNCTIONED¿. THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REGULATORY REPORTING. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE THEM BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 0

REPORTED EVENTS: 1. 2 PATIENTS EXPERIENCED AN INFECTION DURING THE FIRST YEAR AFTER IMPLANT. THE SPINAL CORD STIMULATION (SCS) DEVICES WERE REMOVED AS A RESULT. 2. 10 PATIENTS EXPERIENCED A LOSS OF TREATMENT EFFECT. THE SCS DEVICES WERE REMOVED AS A RESULT. 3. 1 PATIENT HAD THEIR DEVICE REMOVED AFTER 8-10 YEARS OF FOLLOW-UP DUE TO AN ALLERGIC RESPONSE TO NICKEL. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2236739 IMPLANTABLE NEUROSTIMULATOR STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR LGW MEDTRONIC NEUROMODULATION NEU_INS_STIMULATOR UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 56 YR Male Required Intervention